The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-7339
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials ; volume:23 ; number:11 ; day:29 ; month:3 ; year:2015 ; pages:3131-3140 ; date:11.2015
Supportive care in cancer ; 23, Heft 11 (29.3.2015), 3131-3140, 11.2015
- Creator
-
Wang, Li
Baser, Onur
Kutikova, Lucie
Page, John H.
Barron, Richard
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-015-2686-9
- URN
-
urn:nbn:de:101:1-2019080321260009772796
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Li
- Baser, Onur
- Kutikova, Lucie
- Page, John H.
- Barron, Richard
- SpringerLink (Online service)
Other Objects (12)
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer
Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Aggressive Recurrent Pancreatic Cancer Producing Granulocyte Colony-Stimulating Factor
Semisynthesis of Homogeneous, Active Granulocyte Colony‐Stimulating Factor Glycoforms
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?
Role of granulocyte colony-stimulating factor in infection and inflammation
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer
Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Aggressive Recurrent Pancreatic Cancer Producing Granulocyte Colony-Stimulating Factor
Semisynthesis of Homogeneous, Active Granulocyte Colony‐Stimulating Factor Glycoforms
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?
Role of granulocyte colony-stimulating factor in infection and inflammation
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer
Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Aggressive Recurrent Pancreatic Cancer Producing Granulocyte Colony-Stimulating Factor
Semisynthesis of Homogeneous, Active Granulocyte Colony‐Stimulating Factor Glycoforms
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?